Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613001085763
ACTRN12613001085763
Recruiting
Not Applicable

Prospective, randomized, controlled pilot study of aspirin plus nitric oxide donors treatment of recurrent abortion due to primary antiphospholipid syndrome

Benha university hospital0 sites34 target enrollmentSeptember 27, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsrecurrent abortionprimary antiphospholipid syndromeReproductive Health and Childbirth - AbortionInflammatory and Immune System - Autoimmune diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
recurrent abortion
Sponsor
Benha university hospital
Enrollment
34
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Benha university hospital

Eligibility Criteria

Inclusion Criteria

  • •pregnant with recurrent abortion due to primary antiphospholipid syndrone

Exclusion Criteria

  • •recurrent abortion due to anatomical, endocrine and other systemic diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Telehealth Impact in caring for community palliative care patients in a rural settingcancerchronic diseasepalliative care
ACTRN12618000950268Monash Health 40
Completed
Not Applicable
Culturally informed assessment and treatment of chronic paiChronic PainPhysical Medicine / Rehabilitation - Physiotherapy
ACTRN12616000857404iverpool Hospital48
Active, not recruiting
Phase 1
A clinical study to investigate the efficacy and safety of Buparid/PARI SINUS versus Budes® Nasal Spray in the therapy of Chronic Rhinosinusitis (CRS) with nasal polys in adult patientsChronic Rhinosinusitis (CRS) with polyposis nasiTherapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
EUCTR2013-002414-12-DEPARI Pharma GmbH20
Active, not recruiting
Phase 1
A clinical trial to investigate the potential of Buparid/PARI SINUS versus Budes® Nasal Spray to avoid or postpone sinus surgery in adult patients with Chronic Rhinosinusitis (CRS)Chronic Rhinosinusitis (CRS)Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
EUCTR2013-002421-30-DEPARI Pharma GmbH20
Completed
Not Applicable
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home
NL-OMON54917niversitair Medisch Centrum Utrecht50